VAERS Reports UJ654AB

VAERS 2544317

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

schwer

Staat: WA
Alter: 29,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 27.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Confusional state Disorientation Erythema Eye movement disorder Feeling abnormal Loss of consciousness Musculoskeletal stiffness Mydriasis Pallor Respiratory rate increased Vomiting

Symptomtext

Client did fine after receiving the JE, Rabavert, and DPT vaccines. Moments after giving the YF vaccine client c/o feeling funny and confused, stated she was going to pass out. Pupils became dilated eyes rolled up, skin turned bright red, back arched and she became stiff, muscle relaxed then stiffened again, voided, then turned pale. Respirations deep and rapid, pulse easily palpated and regular, approximately 88 bpm. Head down and feet elevated. Slowly regained consciousness and color returned. Post ictal was disoriented and weak. Shortly after regaining consciousness began to vomit . Vomiting off and on for the next hour. Told to go to the ER for anti-emetics if vomiting continued on the way home. Sister was driving her home. Will be staying with father who is an MD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: NKA
Vorherige Impfungen: Had flu like symptoms after last Covid-19 vaccine

VAERS 2616249

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

mild

Staat: OH
Alter: 22,0
Geschlecht: F
Eingang: 17.04.2023
Impfdatum: 13.04.2023
Beginn: 14.04.2023
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Peripheral swelling Pruritus

Symptomtext

Client relates that on Saturday her right arm started to get very red, itchy and swell. The swelling and redness got worse over the weekend and she went to Urgent Care on campus as school today Monday April 17,2023.Client states that she has been taking Ibuprofen and Benadryl 25 mg tablets every 8 hours. Client states that the Urgent care as instructed her to continue with what she has been doing and to call the clinic that gave her the shot. Client denies any other symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: none
Vorgeschichte: Anxiety/Depression, Asthma
Andere Medikamente: FLUOXETINE 20 mg daily Albuterol inhaler 2 puffs as needed
Allergien: NKDA, no other known allergies
Vorherige Impfungen: -

VAERS 2569256

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

mild

Staat: CO
Alter: 63,0
Geschlecht: F
Eingang: 27.01.2023
Impfdatum: 11.01.2023
Beginn: 16.01.2023
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Amnesia Blood glucose normal Injection site erythema Injection site pain Transient global amnesia Troponin increased

Symptomtext

Client reported short-term memory loss the afternoon of 1/16/23 while conversing with family. She does not remember the incident, states family members told her she was repeating questions over and over after being answered. They checked her blood glucose as a diabetic which was WNL, and they took her to an ED. Diagnosis of TGA and elevated troponin. Amnesia resolved around midnight same day, but was inpatient x2d for troponin levels. Client reports no other symptoms other than redness and soreness at injection site prior to amnesia onset. Client was discharged from hospital after resolution of high troponin, no DC medications or plan for follow-up visits.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: 2,0
Labordaten: unknown
Aktuelle Erkrankungen: None known
Vorgeschichte: Type 1 diabetes
Andere Medikamente: Insulin, naproxen, zofran, red yeast rice, fish oil, vitamin D, ferrous sulfate
Allergien: mushrooms
Vorherige Impfungen: -

VAERS 2564511

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge uj654ab

mild

Staat: NY
Alter: 28,0
Geschlecht: F
Eingang: 20.01.2023
Impfdatum: 12.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 7,0
Dosis: N/A
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Musculoskeletal stiffness Neck pain Pain

Symptomtext

Patient developed severe neck pain with stiffness, radiating to shoulders bilaterally. Pain level 9/10 as per patient. She took ibuprofen, acetaminophen - no relief.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536145

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

mild

Staat: OR
Alter: 46,0
Geschlecht: F
Eingang: 18.12.2022
Impfdatum: 16.12.2022
Beginn: 17.12.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Lymph node pain Lymphadenopathy

Symptomtext

Tender left axillary adenopathy, headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: none
Vorgeschichte: moderate persistent asthma, depression, iron deficiency (no anemia)
Andere Medikamente: Welbutrin, albuterol, ferrous gluconate
Allergien: bee stings
Vorherige Impfungen: -

VAERS 2582591

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

gering

Staat: UT
Alter: 22,0
Geschlecht: F
Eingang: 15.02.2023
Impfdatum: 14.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

Patient received a Yellow Fever vaccine after receiving a MMR vaccine on 2/7/2023. The Yellow Fever vaccine is considered not a valid dose due to not being 28 days after the MMR.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578606

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

gering

Staat: NC
Alter: 22,0
Geschlecht: F
Eingang: 09.02.2023
Impfdatum: 06.02.2023
Beginn: 06.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event

Symptomtext

received YF-VAX via intramuscular route instead of subcutaneous route with no reported Adverse event; Initial information was received on 06-Feb-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 22 years old female patient who experienced received yellow fever vaccine -[YF-VAX] via intramuscular route instead of subcutaneous route with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included typhoid vaccine (Typhim) for Immunisation. On 06-Feb-2023, the patient received once a dose of suspect yellow fever vaccine - (strength: standard, lot number: UJ654AB, formulation: Unknown) via intramuscular route in the left deltoid instead of subcutaneous route with no reported adverse event (incorrect route of product administration) (latency: same day). No lab data reported. Action taken: not applicable. Outcome: Unknown for the event received yf-vax via intramuscular route instead of subcutaneous route with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01479362:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: TYPHIM
Allergien: -
Vorherige Impfungen: -

VAERS 2578605

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

gering

Staat: NC
Alter: 27,0
Geschlecht: F
Eingang: 09.02.2023
Impfdatum: 06.02.2023
Beginn: 06.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration Medication error No adverse event

Symptomtext

received YF-VAX via intramuscular route instead of subcutaneous route with no reported adverse event; Initial information received on 06-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 27 years old female patient who experienced received yf-vax via intramuscular route instead of subcutaneous route with no reported adverse event after receiving vaccine yellow fever vaccine - [yf-vax]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included typhoid vaccine polysacch vi (typhim vi) for Immunisation. On 06-Feb-2023, the patient received a 0.5 ml once of standard strength suspect yellow fever vaccine - Solution for injection lot UJ654AB, expiry 11-Oct-2023 via intramuscular route in the left deltoid for Immunization. On 06-Feb-2023 the patient developed a non-serious received yf-vax via intramuscular route instead of subcutaneous route with no reported adverse event (incorrect route of product administration) (Latency: same day). Lab data was not reported. Action taken was not applicable. Outcome was Unknown for the event received yf-vax via intramuscular route instead of subcutaneous route with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01479414:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2533783

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

gering

Staat: PA
Alter: 80,0
Geschlecht: F
Eingang: 16.12.2022
Impfdatum: 12.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event

Symptomtext

She has been giving it subcutaneously, however, today she gave it intramuscularly, wants to know if that was an approved administration route with no reported adverse event; Initial information received on 12-Dec-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves 80 years old female patient and pharmacist was giving it subcutaneously, however, today she gave it intramuscularly(vaccine yellow fever vaccine [YF-Vax]), wants to know if that was an approved administration route with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Dec-2022, the patient received a 0.5 ml dose of suspect yellow fever vaccine with standard strength (frequency: once)(lot UJ654AB and expiry date :10-Nov-2023) (form:unknown) via intramuscular route in the left deltoid for Immunization. On an unknown date the patient developed a non-serious event of event she has been giving it subcutaneously, however, today she gave it intramuscularly, wants to know if that was an approved administration route with no reported adverse event (incorrect route of product administration) (latency: same day) following the administration of yellowfever vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2529481

SANOFI PASTEUR · YELLOW FEVER (YF-VAX) · Charge UJ654AB

gering

Staat: PA
Alter: 80,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 12.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect route of product administration No adverse event

Symptomtext

No adverse event, this was administered IM instead of SQ. Sanofi states unlikely to affect efficacy in administering im instead of sq. Do not repeat dose. prescribing physician states no problem.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: none no adr just reporting
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: not known
Allergien: NKDA
Vorherige Impfungen: -